A securities class action has been filed against Microvast Holdings, Inc. (MVST) behalf of all investors who purchased or otherwise acquired Microvast Holdings securities between April 1, 2025 through March 16, 2026. This case has been filed in the USDC – SDTX.
According to the complaint, during the class period, defendants announced the expansion of its manufacturing facility located in Huzhou, China, dubbing the initiative “Huzhou Phase 3.2”, claiming that its increased production capacity would be online before the end of 2025. Defendants likewise advised investors to expect improved margins, touting a supposed “strategic repositioning away from low-margin segments” and a new “focus . . . towards more profitable, higher-value opportunities”. Notwithstanding, plaintiff alleges that defendants failed to disclose that (i) due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, defendants had overstated Microvast’s ability to reach its margin targets, and (ii) defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025.
A series of disclosures, after which Microvast’s stock declined, revealed the truth about the Company. Microvast’s final disclosure occurred on March 16, 2026, it reported its financial and operating results for the quarter and year ended December 31, 2025. Among other items, Microvast reported that gross margin declined to approximately 1% for the quarter, down sharply from approximately 36% for the same period in the prior year, which the Company attributed to inventory impairment charges arising from “specialized ESS components”. Microvast also reported revenue of $96.5 million for the quarter, representing a 15% year-over-year decrease and falling well short of the consensus estimate of $136.4 million. Microvast attributed this result to “regulatory shifts in South Korea and delays in customer platform ramp-up” in Europe, the Middle East, and Africa. On this news, Microvast’s stock price fell $0.79 per share, or 34.2%, to close at $1.52 per share on March 17, 2026.